Translational medications development for methamphetamine use disorder: A systematic review of preclinical, human laboratory, and clinical research
Alexandra N Johansen, Mark A Smith, William W Stoops · 2026
Read Translational medications development for methamphetamine use disorder: A systematic review of preclinical, human laboratory, and clinical research by Alexandra N Johansen, Mark A Smith, William W Stoops (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13632057.txt.
Description
Alexandra N Johansen and colleagues review the search for medicines to treat methamphetamine use disorder, a 2026 survey of a field with no approved drug therapy. Use remains high and deaths have risen sharply. Few trials have tested candidate medicines. Development has rarely followed the full path from animal work to human lab studies to clinical trials. The authors mapped that path, asking which candidates were tested at each stage and whether results agreed across stages.
Thirty-six randomized, double-blind, placebo-controlled trials covered twenty-five candidate drugs. Only five had also been tested in human lab and animal settings: aripiprazole, bupropion, d-amphetamine, modafinil, and naltrexone. Most studies at every stage showed no change in methamphetamine use. The review urges a more disciplined pipeline, clearer therapeutic targets, and attention to newer regulatory guidance on non-abstinence outcomes.
Catalog record
| CREATOR | Alexandra N Johansen, Mark A Smith, William W Stoops |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 79 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |